All 740 patients who underwent isolated myocardial revascularization procedures from 1967 to 1970 at our institution were compared with'the first 1000 patients who underwent similar elective operations each year from 1971 to 1979. Data from these 9-years were processed through a computerized cardiovascular information registry. In the 1971-1979 period, the patients were olde'r (median age 57 years, compared with 50 years in the 1967-1970 period), more had multivessel disease (90% vs 44%) and more had ventricular asynergy (54% vs 41%). The number of grafts per'patient increased from 1.5 to 2.7, and yet morbidity declined in every category except neurologic deficit. The operative mortality rate was 1.1% from 1967 to 1979'and 1.0% from 1971 to 1979. Graft patency was determined in 475 patients from 1967 to 1970, in'533 patients from 1971, in 519 from 1972, in 540 from 1973 and in 408 from 19741 Patency rates after a mean catheterization interval of 21 months were 77%, 77%, 84%, 87% and 87%, respectively. Fiveand 10-year follow-ups were-completed for the 1967-1970 series and a 5-year follow-up was completed for 1971, 1972, 1973 and 1974 cohorts. The 5-and 10-year actuarial survival rates for'the 1967-1970 series' were 89.4% and 77.3%, respectively. The 5-year survival rates for the 1971-1974 series were 91.9%, 93.4%,' 92.1% and 91.7%. Abnormal ventricular fu'nction and incomplete' revascularization adversely influenced the mortality 'rate (p < 0.05) in all years. The percentage of asymptomatic patients at 5 years was 66%, 65%, 69%, 67% and 74% for thefive patient cohorts. Lower risk and a higher 5-yea'r survival rate are attributable to greater technical experience, changing technology and improved management rather than to selection of lower-risk cases. These 5-and' 10-year survival rates compare favorably with the reported results of medical therapy.
PROGRESS in the surgical treatment of a disease entity is documented by lower operative morbidity and mortality rates and better long-term survival. Such progress has been widely documented for the surgical treatment of coronary atherosclerosis by direct myocardial revascularization. This progress may be the result of refinement in surgical techniques or may be secondary to better patient selection. To evaluate myocardial revascularization as a mode of therapy and to determine why surgical results have improved, the clinical and angiographic variables for the patient groups were examined on a yearly basis and compared with the operative morbidity and mortality. Evaluating the long-term effects of surgical therapy on natural history of progressive atherosclerosis is a difficult assignment with several measurable end points. Survival, however, is the most definite and significant end point; therefore, the 5-and 10-year survival rates will be emphasized in an attempt to evaluate the role of myocardial revascularization in the treatment of coronary atherosclerosis.
Clinical Material For purposes of data retrieval, this 12-year experience was divided into two groups. Our first experience in bypass graft operations consisted of 740 consecutive patients who underwent isolated myocardial revascularization procedures from May 1967 through 'December 1970. These cases'were analyzed and the findings were reported by Sheldon and colleagues.' For comparative purposes, data from the first 1000 patients' who received isolated bypass procedures each year from 1971 to 1979 were processed through a computerized cardiovascular information registry. Emergency revascularization for unstable angina or evolving myocardial infarction, reoperations, bypass procedures combined with aneurysmectomy, carotid endarterectomy, and valve repair or replacement were excluded. Patients with a history of heart failure, recent unstable angina, or infarction within 3 months, and those who had left main coronary obstruction greater than 50% were included. The early experience (1967) (1968) (1969) (1970) ) and the 1000-patient cohorts from 1971 to 1979 constitute our entire experience in elective isolated bypass operations for coronary atherosclerosis. The extent of coronary artery disease and left ventricular function is defined in this study as reported by Loop 
Sex Distribution
Men accounted for approximately 90% of the entire population during the 12-year period.
Age
The median age has gradually increased since 1967-1970. In 1967-1970, the median age was 50 years and in 1979 it was 57 years.
Angina
The distribution of angina remained relatively constant throughout the 12-year experience. Three to 4% of the patients were asymptomatic but most of these patients had experienced a cardiac event. Three to 7% of the-patients were in New York Heart Association functional class I, 47-58% were in class II-III and Critical coronary artery stenosis, estimated at 50% or greater reduction in luminal diameter, was classified as one-, twoor three-vessel disease. The 1967 The -1970 experience was heavily weighted with onevessel disease (56%). Thereafter, the incidence of multivessel disease steadily increased to 90% in 1979. The number of left main lesions increased slightly, from 9% in 1967-1970 to 13% in 1979.
Ventricular Function
The number of patients with left ventricular impairment increased gradually. In 1979, 54% of the patients had asynergy of the ventricle; 15% of these had moderate ventricular impairment and 7% severe impairment. Despite poor ventricular function in some patients, no operations were performed solely for congestive heart failure. 
Completeness of Revascularization
Patients who received grafts to all critically obstructed major vessels greater than 1 mm in diameter were classified as completely revascularized. From 1971 to 1979, the number of grafts per patient steadily increased from 1.5 to 2.7 and the percentage of patients who underwent complete revascularization rose from 58% in 1971 to 88% in 1979. Cerebrovascular accident. Neurologic deficits occurred in 0.9-2.2% of the patients. Approximately 50% of the deficits were transient. There has been no trend in the incidence of this complication.
Morbidity
Gastrointestinal bleeding. The incidence of stress gastrointestinal bleeding gradually decreased after 1973. Before then, the incidence ranged from 1.4% to 2.6%. In the last 2000 cases in this series, there were only two cases of intestinal bleeding.
Wound complications. Superficial or mediastinal infection and sternotomy dehiscence gradually decreased from 2.9% in 1971 to 1.5% in 1979.
Long-term Survival
All survival data represent gross survival, not cardiac survival only, and include hospital mortality. The Actuarial survival for the 1971-1974 cohorts ( fig. 1 ) was 95.6% (n = 682) for one-vessel disease, 93.1% (n = 1365) for two-vessel disease and 89.7% (n = 1953) for three-vessel disease. In the subset of patients with left main disease, survival at 5 years was 88.0% (n = 391).
In isolated one-vessel disease for the 1971-1974 combined cohorts ( fig. 2 ), patients with a graft to the anterior descending coronary artery had the highest 5year survival, 97.4% (n = 458), followed by isolated right coronary artery, 95.0% (n = 171) and circumflex coronary artery, 91.0% (n = 50).
Abnormal left ventricular function adversely influenced survival in all the years (fig. 3 ). In (fig. 4 ).
Ten-year survival for the 1967-1970 series was 77.3% overall, and was 81.3% (n = 414) for one-vessel disease, 75.9% (n = 195) for two-vessel disease, 62.3% (n = 69) for three-vessel disease and 72.9% (n = 63) for left main disease ( fig. 5 ).
Symptomatic Status
Five-year survivors from the 1967-1974 series were interviewed by telephone regarding the presence or absence of chest pain. No cohorts, 553, 519, 540 and 408, respectively, were studied at a mean interval of 21 months. Vein graft patency improved slightly, from 74.9% in 1970 to 83.7% in 1974. Vein graft patency was slightly higher for the left anterior descending coronary artery (83.2%) than for the right (77.4%) or the circumflex (78.1%) arteries (table 5) . The use of the internal mammary artery as a conduit was introduced in 1970. The patency for 623 grafts studied at a mean interval of 14 months was 94.5%. This patency rate remained constant from 1971 through 1974 (table 6) .
The patency of saphenous vein grafts and internal mammary artery grafts placed to the left anterior descending coronary artery was compared. The patency rate was 83.2% for 1116 saphenous vein grafts and was 94.8% for 578 internal mammary artery grafts (table 7) .
Discussion
During the 12-year period of this study, the preoperative risk factors increased substantially. The median age steadily increased from 50 to 57 years. The percentage of patients with multivessel disease increased from 44% in 1967-1970 to 90% in 1979. This increase was associated with a gradual worsening of The percent values represent the percentage of patent grafts. During this same period, the operative mortality rate declined from 3% in 1967-1970 to 1.0% in 1971-1979, even though the surgical procedure became more extensive, with the percentage of patients achieving complete revascularization increasing to 88% in 1979. The higher-risk population and more extensive surgery were not associated with increasing morbidity; in contrast, the incidence of perioperative infarction decreased from 7.1% in 1967-1970 to 1.5% in 1979, most notably after the introduction of cold cardioplegia in 1977. This improvement in myocardial protection is substantiated by the reduction in mean peak SGOT, from 71 IU/I in 1975 to 41 IU/I in 1979.
11-40 CIRCULATION
Improved blood utilization has further contributed to the reduction in operative morbidity. Blood utilization averaged 9-7.5 units per patient until 1977, when an aggressive program of blood conservation was instituted that reduced the number of units to 1.4 per patient in 1979, with 60% of the patients receiving no blood or blood products during their hospitalization. Concomitant with this was a decrease in the rate of reexploration for bleeding, from 10% in the early years to 2.5% in 1979. Clearly, progress in the past decade can be attributed to rapid improvement in techniques, technical ability and perioperative management skills, rather than to selection of patients.
Coronary atherosclerosis is a biologically progressive disease; therefore, the results of any form of therapy must be evaluated over an extended period. A considerable amount of data is available at 5 years to evaluate the medium-term results, but the long-term results will not be known until 10-, 15-and 20-year survival data are available. Comparison of medical and surgical treatment has been made by randomized prospective studies,3'the case-control method (matched series),7 8 and the retrospective cohort study.>'2 Each is imperfect because of the patient pop- ulation and the time of study. Randomized prospective studies suffer because high-risk patients are removed through the selection process, and the crossover from medical to surgical treatment leaves a lower-risk population. The retrospective cohort, often termed retrospective analysis, has been criticized because it includes patients who underwent angiography and treatment before the advances in drug treatment in the 1970s. Most of these latter series included the full spectrum of coronary heart disease and did not specifically separate surgical candidates. One exception is the report by Proudfit et al.12 of a series of 388 patients designated as eligible surgical candidates. These were patients with an estimated 60% or greater proximal major coronary narrowing supplying contractile myocardium and without severe left ventricular impairment. The slope of the survival curve of these surgical candidates parallels the survival curve of the composite group, but it is set at a higher level because patients with poor left ventricular function have been excluded.
To obtain a range of the reported results of medical therapy, we summarized the 5-year survival of medically treated patients from these three methods of comparison (table 8) . When patients with one-vessel disease are compared, a consistent 2-3% attrition rate per year is observed regardless of method. The randomized and matched patients show significant differences in 5-year survival for two-and three-vessel disease compared with the retrospective cohort study. (table 9) . Progress in survival is apparent within the surgical series, with improvement for one-, two-and three-vessel disease between the 1967-1970 series and 1971-1974 cohort.
Left main obstructions were the first to be recognized for their malignant natural history, and were the first subset generally agreed to be preferentially treated surgically. The data from The Cleveland has dropped dramatically. In 1979, there were four deaths in 296 procedures; this appreciably lower operative mortality rate may soon remove left main disease from the list of variables that adversely influence operative mortality. Evaluation of long-term results is more difficult with the limited data for both the medical and surgical results. The initial 10-year surgical results reported by Sheldon et al.'4 suffer from a disproportionate percentage of one-vessel disease. Although better balanced, the series of Lawrie et al.'" of 250 patients includes 68% with one-and two-vessel disease. Since these patients underwent surgery, there has been a rapid evolution in surgical management with a lower mortality and perioperative infarction rate and more complete revascularization, making these results of historic interest and a benchmark against which to judge future results, but of limited value in the decision on current treatment. The series of Proudfit et al.'2 is the most useful medical series against which to compare these 10-year results. The surgical results for the entire series are better than results achieved with medical treatment (fig. 6 ).
The 5-year survival rate was better in the surgical series than in the medical series, a trend confirmed by the data available for 10-year surgical survival. However 5-and 10-year surgical results will continue to improve because of better myocardial protection, more complete revascularization, and higher patency rates associated with the use of the internal mammary artery graft. References IN A SERIES of early reports from this institution, the favorable clinical and angiographic results of coronary bypass surgery were documented for patients followed for as long as 4 years after operation.'-" The largest of these series consisted of 1287 patients followed 6 months to 4 years.8 Of these patients, 51% were free of angina and about 40% were improved. At that time, 77% of patients had returned to work. Graft patency was reported for 325 patients and was 85%. During this period of follow-up, 93.6% of patients remained alive. During the subsequent 10 years, these observations have been extended systematically and now provide some insight into the long-term (5-10-year) results of coronary bypass, particularly in relation to long-term survival rates and factors thought to influence them, such as late vein graft patency, vein graft pathologic changes, progression of coronary atherosclerosis, and other pre-and intraoperative variables.
In 1977 and 1978, two studies of the survival rates of patients who had been followed for at least 5 years after coronary bypass surgery were reported.' 7 Lawrie et al." reported that in this earliest surgical experience, the perioperative mortality rate was 7.1%, but that the annual attrition rate was 2.3% after the first year. This approximated the expected annual attrition rate of the general U.S. population after correction for age and sex.
In a more detailed 5-year study,7 the perioperative mortality was 5.4% for 792 consecutive patients, but was reduced to 4.8% in the latter part of this still early experience. The overall full 5-year survival rates by subgroups in this study were 93.9% for one-, 90.2% for two-and 85.1% for three-vessel disease. Survival for all 792 patients was 89.3% at 5 years. In both of these studies, men and women had similar late survival rates.
A study of the survival of 1144 consecutive patients at least 5 years after operation was also reported in 1978.1 One thousand of the patients (87.4%) were men. The mean age was 50.1 years (range 24-75 years). In 1101 patients (96.2%), the indication for operation was angina with reduction of more than 70% of the luminal diameter of the coronary arteries. Forty-three patients (3.8%) had coronary bypass because of congestive heart failure without angina; 240 (21%) had both angina and congestive heart failure. One hundred forty-nine patients (13%) had unstable angina and 675 (59%) had previous myocardial infarction. Two hundred twenty-six patients (19.8%) had more than 70% stenosis in one vessel, 442 (38.6%) in two vessels and 376 (32.9%) in three vessels. In 100 patients (8.7%), left main coronary artery stenosis was greater than 50%.
The operative mortality rate for the entire series was 4.6% (52 patients). The operative mortality rate for all patients except those with disease of the left main coronary artery was 3.8% (40 of 1044). The crude 5-year survival rate was 89.1% (930/1044). The survival rates in males and females were similar.
Left ventricular function was classified as good if the end-diastolic pressure was less than 15 mm Hg and there was no evidence of aneurysm or akinesis in the left ventriculogram. The survival rates of the men II-43
